India to Egypt: Bevacizumab Export Trade Route
India has recorded 16 verified shipments of Bevacizumab exported to Egypt, representing a combined trade value of $718.4K USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $44.9K USD. The leading Indian exporter is BIOCON BIOLOGICS INDIA LIMITED, which accounts for 78% of total export value with 7 shipments worth $561.7K USD. On the buying side, BIOCON BIOLOGICS UK LIMITED is the largest importer in Egypt with $561.7K USD in purchases. The top 3 suppliers — BIOCON BIOLOGICS INDIA LIMITED, HEALTHBIOTICS PRIVATE LIMITED, AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED — together control 93% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Egypt Bevacizumab corridor is one of India's established pharmaceutical export routes, with 16 shipments documented worth a combined $718.4K USD. The route is dominated by BIOCON BIOLOGICS INDIA LIMITED, which alone accounts for roughly 78% of all export value, reflecting the consolidated nature of India's bevacizumab manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $44.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with bevacizumab's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 30.9%, placing it at rank #17 among India's top bevacizumab export destinations globally.
On the import side, key buyers of Indian bevacizumab in Egypt include BIOCON BIOLOGICS UK LIMITED, ROYAL MEDICAL AMREYA PUBLIC FREE, ROYAL PHARMACEUTICALS L L FZ and 7 others. BIOCON BIOLOGICS UK LIMITED is the single largest importer with 1 shipments valued at $561.7K USD.
Route Characteristics
- Average transit25 days
- Peak seasonQ3
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#17
- Annual growth+30.9%
- Demand growth+27.6%
- Regulatory ease80/100
Top 10 Indian Bevacizumab Exporters to Egypt
Showing top 10 of 7 Indian suppliers exporting Bevacizumab to Egypt, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BIOCON BIOLOGICS INDIA LIMITED Avg $80.2K per shipment | 7 | $561.7K | 78.2% |
| 2 | HEALTHBIOTICS PRIVATE LIMITED Avg $37.8K per shipment | 2 | $75.5K | 10.5% |
| 3 | AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED Avg $29.0K per shipment | 1 | $29.0K | 4.0% |
| 4 | AL ROYAL PHARMACEUTICAL PRIVATE LIMITED Avg $27.4K per shipment | 1 | $27.4K | 3.8% |
| 5 | AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED Avg $13.2K per shipment | 1 | $13.2K | 1.8% |
| 6 | J.A. UNITED EXPORTS PRIVATE LIMITED Avg $10.2K per shipment | 1 | $10.2K | 1.4% |
| 7 | RELIANCE LIFE SCIENCES PRIVATE LIMITED Avg $418 per shipment | 3 | $1.3K | 0.2% |
This table shows the top 10 of 7 Indian companies exporting bevacizumab to Egypt, ranked by total trade value. The listed exporters are: BIOCON BIOLOGICS INDIA LIMITED, HEALTHBIOTICS PRIVATE LIMITED, AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED, AL ROYAL PHARMACEUTICAL PRIVATE LIMITED, AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED , J.A. UNITED EXPORTS PRIVATE LIMITED, RELIANCE LIFE SCIENCES PRIVATE LIMITED. BIOCON BIOLOGICS INDIA LIMITED is the dominant supplier with 7 shipments worth $561.7K USD, giving it a 78% market share. The top 3 suppliers together account for 93% of the total trade value on this route.
Top 10 Bevacizumab Importers in Egypt
Showing top 10 of 10 known buyers in Egypt receiving Bevacizumab shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian bevacizumab in Egypt include BIOCON BIOLOGICS UK LIMITED, ROYAL MEDICAL AMREYA PUBLIC FREE, ROYAL PHARMACEUTICALS L L FZ, ROYAL PHARMACEUTICALS L L C FZ, ROYAL MEDICAL AMREYA PUBLIC FREE , among 10 total buyers. The largest importer is BIOCON BIOLOGICS UK LIMITED, accounting for $561.7K USD across 1 shipments — representing 78% of all bevacizumab imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BIOCON BIOLOGICS UK LIMITED | 1 | $561.7K | 78.2% |
| 2 | ROYAL MEDICAL AMREYA PUBLIC FREE | 2 | $56.4K | 7.9% |
| 3 | ROYAL PHARMACEUTICALS L L FZ | 1 | $37.8K | 5.3% |
| 4 | ROYAL PHARMACEUTICALS L L C FZ | 1 | $37.8K | 5.3% |
| 5 | ROYAL MEDICAL AMREYA PUBLIC FREE | 1 | $13.2K | 1.8% |
| 6 | AL-NOOR FOR DRUGS & MEDICAL | 1 | $10.2K | 1.4% |
| 7 | EGYPTIAN INTERNATIONAL PHARMA CEUTI | 3 | $1.3K | 0.2% |
| 8 | XXOGEXXRICXXHARXX S XXE | 3 | $10 | 0.0% |
| 9 | XXoGeXXricXXharXX S XXE | 2 | $5 | 0.0% |
| 10 | BIOGENERIC PHARMA S A E | 1 | $5 | 0.0% |
Top 10 Bevacizumab Formulations Imported by Egypt
Showing top 10 of 12 product formulations shipped on the India to Egypt Bevacizumab route, ranked by trade value
Egypt imports a wide range of bevacizumab formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — BEVACIZUMAB INJECTION — accounts for $561.7K USD across 3 shipments. There are 12 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BEVACIZUMAB INJECTION | 3 | $561.7K | 78.2% |
| 2 | ABEVMY 400 BEVACIZUMAB INJECTION 1 VIAL 16ML AS PER INVOICE AND PACKING LIST | 2 | $75.5K | 10.5% |
| 3 | BEVACIZUMAB 400MG INJ B/N- BF22002942, B | 1 | $29.0K | 4.0% |
| 4 | BEVACIZUMAB 400MG INJ TAB B NO BF21002406 BF21005266 BF22002942 BF22004523 M DT 09 21 02 22 09 22 E DT 08 24 01 25 8 25 | 1 | $27.4K | 3.8% |
| 5 | BEVACIZUMAB 400MG INJ ABEVMY INJ BN.BF22 | 1 | $13.2K | 1.8% |
| 6 | Bevacizumab 400mg/16 ml - Cizumab 400 Composition: Each ml of concentrate contains 25 mg of Bevacizumab 16 ml of vial co | 1 | $10.2K | 1.4% |
| 7 | BEVACIZUMAB 400 MG | 1 | $638 | 0.1% |
| 8 | BEVACIZUMAB 100 MG | 1 | $530 | 0.1% |
| 9 | BEVACIZUMAB INTERNAL REFRENCE STANDARD | 1 | $84 | 0.0% |
| 10 | BEVACIZUMAB ASSAY CONTROL | 2 | $4 | 0.0% |
Showing top 10 of 12 Bevacizumab formulations imported by Egypt on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 77%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 3 shipments. Transit time averages 25 days by sea.
Market Dynamics
India's bevacizumab exports to Egypt are driven primarily by a handful of large-scale manufacturers. BIOCON BIOLOGICS INDIA LIMITED with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Egypt benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — BIOCON BIOLOGICS INDIA LIMITED, HEALTHBIOTICS PRIVATE LIMITED, AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED — together account for 93% of total trade value on this route. The average shipment value of $44.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as abevmy 400 bevacizumab injection 1 vial 16ml as per invoice and packing list and bevacizumab 400mg inj b/n- bf22002942, b, suggesting that buyers in Egypt tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, BIOCON BIOLOGICS UK LIMITED is the largest importer with 1 shipments worth $561.7K USD — representing 78% of all bevacizumab imports from India on this route. A total of 10 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $718.4K
- Avg. Shipment
- $44.9K
- Suppliers
- 7
- Buyers
- 10
- Transit (Sea)
- ~25 days
- Annual Growth
- +30.9%
Related Analysis
Other Bevacizumab Routes
Unlock the Full India to Egypt Bevacizumab Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 16 shipments on this route.
Frequently Asked Questions — India to Egypt Bevacizumab Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Bevacizumab to Egypt?
The leading Indian exporters of Bevacizumab to Egypt are BIOCON BIOLOGICS INDIA LIMITED, HEALTHBIOTICS PRIVATE LIMITED, AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED. BIOCON BIOLOGICS INDIA LIMITED holds the largest market share at approximately 78% of total trade value on this route.
Q What is the total value of Bevacizumab exports from India to Egypt?
India exports Bevacizumab to Egypt worth approximately $718.4K USD across 16 recorded shipments. The average value per shipment is $44.9K USD.
Q Which ports does India use to ship Bevacizumab to Egypt?
The most active port of origin is SAHAR AIR with 3 shipments. Indian exporters primarily use sea freight for this route, with 77% of shipments going by sea and 24% by air.
Q How long does shipping take from India to Egypt for Bevacizumab?
The average transit time for Bevacizumab shipments from India to Egypt is approximately 25 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Egypt Bevacizumab trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 30.9% with demand growth tracking at 27.6%. The route is ranked #17 among India's top Bevacizumab export destinations globally.
Q How many suppliers are active on the India to Egypt Bevacizumab route?
There are currently 7 active Indian suppliers exporting Bevacizumab to Egypt. The market is moderately concentrated with BIOCON BIOLOGICS INDIA LIMITED accounting for 78% of total shipment value.
Q Who are the main importers of Bevacizumab from India in Egypt?
The leading importers of Indian Bevacizumab in Egypt include BIOCON BIOLOGICS UK LIMITED, ROYAL MEDICAL AMREYA PUBLIC FREE, ROYAL PHARMACEUTICALS L L FZ, ROYAL PHARMACEUTICALS L L C FZ, ROYAL MEDICAL AMREYA PUBLIC FREE . BIOCON BIOLOGICS UK LIMITED is the largest buyer with 1 shipments worth $561.7K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Egypt export trade corridor identified from Indian Customs (DGFT) records for Bevacizumab.
- 2.Supplier/Buyer Matching: 7 Indian exporters and 10 importers in Egypt matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 16 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
16 Verified Shipments
7 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists